Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05019794
What this trial is testing

Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaSolid Tumor
LianBio LLC 80
Early research (Phase 1)Not Yet RecruitingNCT06755242
What this trial is testing

GNC-077 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Who this might be right for
Gastrointestinal TumorsSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 20
Early research (Phase 1)Study completedNCT01875705
What this trial is testing

A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Genentech, Inc. 40
Early research (Phase 1)Study completedNCT00848718
What this trial is testing

A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003)

Who this might be right for
Locally Advanced, Metastatic Solid Tumors
Merck Sharp & Dohme LLC 77
Testing effectiveness (Phase 2)Looking for participantsNCT06016062
What this trial is testing

RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors

Who this might be right for
Solid Tumor
RemeGen Co., Ltd. 221
Early research (Phase 1)Looking for participantsNCT06826313
What this trial is testing

Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Guangzhou Virotech Pharmaceutical Co., Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06827613
What this trial is testing

Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors

Who this might be right for
Triple Negative Locally Advanced Non-resectable Breast CancerHR+, HER2-, Advanced Breast Cancer
Marengo Therapeutics, Inc. 50
Testing effectiveness (Phase 2)Ended earlyNCT04084366
What this trial is testing

Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
OBI Pharma, Inc 44
Early research (Phase 1)Looking for participantsNCT06686745
What this trial is testing

Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Early research (Phase 1)Study completedNCT00106145
What this trial is testing

A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014)

Who this might be right for
Advanced Breast CancerOther Solid Tumors
Merck Sharp & Dohme LLC 103
Testing effectiveness (Phase 2)Looking for participantsNCT07287995
What this trial is testing

ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 428
Early research (Phase 1)UnknownNCT01932177
What this trial is testing

EVESOR: a Phase 1 Trial of Everolimus and Sorafenib

Who this might be right for
Metastatic or Locally Advanced Solid Tumors
Hospices Civils de Lyon 60
Early research (Phase 1)Study completedNCT05101109
What this trial is testing

Study to Evaluate the Safety and Tolerability of ABL501, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL501 in Subjects With Any Progressive, Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
ABL Bio, Inc. 24
Testing effectiveness (Phase 2)UnknownNCT05390528
What this trial is testing

A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma

Who this might be right for
Advanced TumorsLymphomaMetastatic Tumors
Shanghai Henlius Biotech 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07739966
What this trial is testing

DS-3939a in Participants With Solid Tumors

Who this might be right for
Solid TumorLocally Advanced Non-Small Cell Lung CancerMetastatic Non-Small Cell Lung Cancer
Daiichi Sankyo 400
Not applicableStudy completedNCT05236257
What this trial is testing

A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib From a Study Called SCOUT With Patient Data From an External Database

Who this might be right for
Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene FusionInfantile Fibrosarcoma
Bayer 93
Early research (Phase 1)Looking for participantsNCT07279428
What this trial is testing

BL-M24D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Who this might be right for
Gastrointestinal TumorsSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 33
Early research (Phase 1)Study completedNCT03071757
What this trial is testing

The Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 139
Early research (Phase 1)Active Not RecruitingNCT03821935
What this trial is testing

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 364
Testing effectiveness (Phase 2)Ended earlyNCT06198426
What this trial is testing

IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 5
Next Page